What's happening
This bill repeals a 2022 law about determining New York's eligibility for federal funding of prescription digital therapeutics.
Why it matters
Potentially limits state support for digital therapeutics. By repealing the 2022 law, New York might no longer actively seek federal funding for prescription digital therapeutics, which could reduce incentives for integrating these technologies into Medicaid or other state-supported health programs.
May slow adoption of innovative treatments. Prescription digital therapeutics are emerging tools for managing health conditions (like mental health or substance use disorders). Without the push to secure federal funding, adoption and coverage for these therapies could be slower, affecting patient access to new forms of care.
Signals a shift in legislative priorities. The repeal suggests lawmakers are reconsidering the importance or feasibility of pursuing federal financial participation for these products, which may reflect concerns about costs, efficacy, or regulatory challenges. This could influence how New York approaches digital health innovation in the future.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Repeal Digital Therapy Coverage
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Signed chap.39
- Delivered to governor
- Returned to assembly
- Passed senateVote 62–0
- 3rd reading cal.65
- Substituted for S856
- Referred to rules
- Delivered to senate
- Passed assembly
- Ordered to third reading rules cal.14
- Rules report cal.14
- Reported
Show 2 earlier actions
- Reported referred to rules
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
End Digital Drug Program
Senate Floor Calendar · Sponsor Pete Harckham
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
988
2023-2024 Regular Sessions
IN ASSEMBLY
January 11, 2023
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Health
AN ACT to repeal section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A.
3642, in relation to prescription digital therapeutics
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 1 of a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, is REPEALED.
§ 2. This act shall take effect on the same date and in the same manner as a chapter of the laws of 2022 relating to determining whether the state can claim federal financial participation for coverage of and payment for certain prescription digital therapeutics, as proposed in legislative bills numbers S. 559 and A. 3642, takes effect.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD04214-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.